Boustani

NY Goat Yoga at Gilbertsville Farmhouse Announces 2022 Retreat Schedule

Retrieved on: 
Wednesday, March 16, 2022
GLOBE, Barstool Sports, Breakfast, Wine, The Drew Barrymore Show, Sun, Summer Food Service Program, Animal, Drink, Goat, Gilbertsville, Couples Retreat, Student, Rest, Aldo, NEW, Yoga, Drinking, The Untitled Action Bronson Show, Eating, Travel, Hug, Relaxation, College Tour, Boustani, Nightclub, Hotel, Restaurant, Adult, Henry Shull Farmhouse Inn, Food

SOUTH NEW BERLIN, N.Y., March 16, 2022 (GLOBE NEWSWIRE) -- NY Goat Yoga , New York's first-ever goat yoga operation, has officially announced its 2022 retreat schedule.

Key Points: 
  • SOUTH NEW BERLIN, N.Y., March 16, 2022 (GLOBE NEWSWIRE) -- NY Goat Yoga , New York's first-ever goat yoga operation, has officially announced its 2022 retreat schedule.
  • The classic Goat Yoga Retreat is exactly what it sounds like - this retreat isall about the goats and the yoga.
  • Guests start the retreat with a sunset goat yoga class and end it with a nighttime, candlelit, hip-hop yoga class.
  • NY Goat Yoga , New York's first-ever goat yoga operation, is the brainchild of Aldo & Sharon Boustani.

Boehringer Ingelheim's Carine Boustany Appointed to BIO Board

Retrieved on: 
Tuesday, November 16, 2021
Quality of life, Corporate social responsibility, Boehringer Ingelheim, Secondary research, Organization, Heart, Discovery, CEO, Department, D, CA, Boustani, Multimedia, Boehringer Ingelheim Animal Health, Research, Policy, Animal Health, Animal, Health, Association, Human, Development, Partnership, Biotechnology, Access, BIO, Patient, Life, Management, Fine chemical

RIDGEFIELD, Conn., Nov. 16, 2021 /PRNewswire/ --Boehringer Ingelheim announced today that Carine Boustany, Ph.D., Global Head, Development Science + Head, Development Site U.S., hasbeen appointed to the BIO Board of Directors.In this role, she will also serve on the Health Section Governing Board and Access and Value Committee.

Key Points: 
  • RIDGEFIELD, Conn., Nov. 16, 2021 /PRNewswire/ --Boehringer Ingelheim announced today that Carine Boustany, Ph.D., Global Head, Development Science + Head, Development Site U.S., hasbeen appointed to the BIO Board of Directors.In this role, she will also serve on the Health Section Governing Board and Access and Value Committee.
  • "BIO plays a pivotal role in advancing innovation in biotechnology on a global scale and I am honored and excited to represent Boehringer Ingelheim and help drive our shared mission of progressing science toward delivering innovative medicines for the patients," said Carine Boustany.
  • "We are excited to welcome Carine Boustany to the BIO Board of Directors.
  • Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and is part of the Boehringer Ingelheim group of companies.In addition, there are Boehringer Ingelheim Animal Health in Duluth, GA and Boehringer Ingelheim Fremont, Inc. in Fremont, CA.